Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acupressure versus fluoxetine for premenstrual syndrome
IRCT20190430043433N1Phase 3Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of fluoxetine in premenstrual syndrome (PMS) (3 arms), sponsored by Qazvin University of Medical Sciences. Primary endpoint: Physical and psychosomatic symptoms of premenstrual syndrome. Started May 2019; status: completed.
02
Drugs
fluoxetine
03
Conditions
premenstrual syndrome (PMS)
Beyond the preview
Go deeper on IRCT20190430043433N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190430043433N1.